Corcept Therapeutics Incorporated
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-18.0M | $-18.0M | — | $1.8M |
| FY2010 | $-22.3M | $-22.3M | — | $2.1M |
| FY2011 | $-27.4M | $-27.4M | $25.0K | $3.4M |
| FY2012 | $-36.0M | $-36.2M | $151.0K | $5.3M |
| FY2013 | $-37.1M | $-37.2M | $127.0K | $5.2M |
| FY2014 | $-27.4M | $-27.6M | $174.0K | $5.2M |
| FY2015 | $3.1M | $3.1M | $17.0K | $6.0M |
| FY2016 | $18.4M | $18.2M | $194.0K | $7.1M |
| FY2017 | $60.9M | $60.5M | $419.0K | $13.4M |
| FY2018 | $115.7M | $115.4M | $298.0K | $23.7M |
| FY2019 | $136.1M | $135.0M | $1.1M | $29.3M |
| FY2020 | $152.0M | $150.7M | $1.2M | $33.5M |
| FY2021 | $167.9M | $167.4M | $469.0K | $42.9M |
| FY2022 | $120.3M | $119.9M | $413.0K | $42.4M |
| FY2023 | $126.7M | $126.5M | $139.0K | $48.9M |
| FY2024 | $198.3M | $196.1M | $2.2M | $61.4M |
| FY2025 | $142.0M | $141.8M | $211.0K | $84.5M |